ELISAFE: Baseline characteristics from an observational study to evaluate real-world safety of eliglustat in patients with Gaucher disease

被引：0
|
作者：
Batsu, Isabela [1 ]
Accomando, Beverly [1 ]
Gaemers, Sebastiaan J. M. [2 ]
Sekulic, Davorka [1 ]
机构：
[1] Sanofi, Cambridge, MA USA
[2] Sanofi, Amsterdam, Netherlands
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2021.11.036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
21
引用
收藏
页码：S21 / S22
页数：2
相关论文
共 50 条
  • [1] Patient reported outcomes of patients with Gaucher disease type 1 treated with eliglustat in real-world settings: The ELIPRO study
    Camou, Fabrice
    Lagadec, Audrey
    Coutinho, Angela
    Berger, Marc G.
    Cador-Rousseau, Berengere
    Gaches, Francis
    Belmatoug, Nadia
    MOLECULAR GENETICS AND METABOLISM, 2023, 140 (03)
  • [2] Bone disease in eliglustat treated Gaucher disease type 1 patients: A real-world experience in a tertiary referral hospital
    Valls-Villalba, Angel
    Camprodon-Gomez, Maria
    Moreno-Martinez, Daniel
    Hernandez-Vara, Jorge
    Arranz-Amo, Jose Antonio
    Carnicer-Caceres, Clara
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 129 - 129
  • [3] Effectiveness and safety of finerenone in diabetic kidney disease patients: a real-world observational study from China
    Zhou, Jingying
    Kang, Le
    Gu, Chenjie
    Li, Xinwei
    Guo, Xianan
    Fang, Ming
    RENAL FAILURE, 2024, 46 (02)
  • [4]  A global, observational, cohort study of patients with atopic dermatitis to evaluate tralokinumab real-world clinical use (TRACE): baseline characteristics from the first 100 patients in Germany
    Thaci, Diamant
    Kleinheinz, Andreas
    Anastasiadou, Dimitra Maria
    Stinson, John
    Armstrong, April W.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [5] Real-world observational study of MVASI in metastatic colorectal cancer patients in Canada: Baseline patient characteristics
    Cheung, W.
    Samimi, S.
    Kassam, S.
    Colwell, B.
    Meyer, P.
    Knight, G.
    Ma, K.
    Eberg, M.
    Mancini, J.
    Alemayehu, M.
    Martinez, D.
    Packalen, M.
    Wani, R.
    Ngan, E.
    Du, Y.
    Inam, N.
    ANNALS OF ONCOLOGY, 2022, 33 : S257 - S257
  • [6] Real-world effectiveness of eliglustat in treatment-naive and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry
    Mistry, Pramod K.
    Balwani, Manisha
    Charrow, Joel
    Kishnani, Priya
    Niederau, Claus
    Underhill, Lisa H.
    McClain, Monica R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) : 1038 - 1046
  • [7] Real-World, Observational, Retrospective Study to Evaluate the Effectiveness and Safety of Treatment with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
    Csipak, Angelica Richart
    da Fonseca, Leonardo G.
    Lopez, Rossana Veronica Mendoza
    Estevez-Diz, Maria Del Pilar
    CURRENT ONCOLOGY, 2024, 31 (11) : 6778 - 6790
  • [8] Long-term effectiveness of eliglustat treatment: A real-world analysis from the International Collaborative Gaucher Group Gaucher Registry
    Mistry, Pramod K.
    Balwani, Manisha
    Charrow, Joel
    Lorber, Jeremy
    Niederau, Claus
    Carwile, Jenny L.
    Oliveira-dos-Santos, Antonio
    Perichon, Maria Gabriela
    Uslu Cil, Sefika
    Kishnani, Priya S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1500 - 1510
  • [9] Cancer Risk in Patients with Gaucher Disease Using Real-World Data
    Revel-Vilk, Shoshana
    Zimran, Ari
    Istaiti, Majdolen
    Manor, Orly
    Shalev, Varda
    Azani, Litat
    Chodick, Gabriel
    Paltiel, Ora
    BLOOD, 2023, 142
  • [10] Cancer Risk in Patients with Gaucher Disease Using Real-World Data
    Revel-Vilk, Shoshana
    Zimran, Ari
    Istaiti, Majdolen
    Azani, Liat
    Shalev, Varda
    Chodick, Gabriel
    Manor, Orly
    Paltiel, Ora
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
12345